Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000129

Director sold 786 shares at $21.00 ($16,506)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pauls Matthew Director 2026-10-02 Sale 10b5-1 −786 $21.00 $16,506 13,578 D: show line 1 in the form
Open-market sales · 786 sh · avg $21.00 · $16,506
Loading xslF345X06/wk-form4_1791323618.xml…